Posted on Feb 20, 2020

Healthcare Medical Pharmaceutical Directory

Learn About Horizon Therapeutic's Recently Approved Active Thyroid Eye Disease Drug Tepezza (teprotumumab-trbw).

Granted Orphan Drug Status by the FDA, Tepezza is a monoclonal antibody (mAb) that provides vision care clinicians and other medical professionals a new option to treat this rare disease.

Go straight to our home page by clicking "Learn More" below and click on the eyeball featured in our scrolling display...
Contact Us
Message sent. We'll get back to you soon.